Hepatitis B genotypes and the response to interferon therapy
about
High rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.Molecular mechanism and treatment of viral hepatitis-related liver fibrosis.Advancing patient care: integrating new data.Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India.Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of BrazilBinding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H.Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma.Mutations within enhancer II and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia.Diagnosis and management of pre-core mutant chronic hepatitis B.Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Hepatitis B viral genotypes: clinical relevance and molecular characteristics.Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey.Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand.Clinical relevance of viral dynamics and genotypes in hepatitis B virus.Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injectionEtiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in ColombiaCurrent therapies for chronic hepatitis B virus infection.Adefovir dipivoxil in chronic hepatitis B infection.Emerging treatments in chronic hepatitis B.Hepatitis B virus: significance of genotypes.Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene.Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons.End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment.Influence of HLA-DRB1 alleles and HBV genotypes on interferon-alpha therapy for chronic hepatitis B.Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy.A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study.Therapeutic implications of hepatitis B virus genotypes.Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.Therapeutic options for chronic hepatitis B: considerations and controversies.Lower Viral Response to Pegylated Interferon Alpha 2a Treatment of Chronic Hepatitis B in Roma People in Eastern SlovakiaEstablished and emerging therapies for the treatment of viral hepatitis.Recommendations and potential future options in the treatment of hepatitis B.Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.Stronger enhancer II/core promoter activities of hepatitis B virus isolates of B2 subgenotype than those of C2 subgenotype.Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.
P2860
Q24814210-893AEC23-7D48-4AA0-ADFE-9C4EEAFE28DFQ27692609-0B53CC50-962F-45B0-8690-6ED87A70E225Q31031231-1BA6BCD4-B872-454C-AA45-EA79012250DEQ33202621-446FBD68-DC30-431B-8D4D-19323241BE58Q33500835-A8BAAA3A-B616-4444-9AC0-E48ED94BC1F8Q33572382-DCD9B060-4D12-4D60-ACBD-EC9C99D4886BQ33909717-75A099B3-CE31-4694-A2D2-0646EA5084BBQ34017729-3DC0FC84-5BA8-4FB4-BAEF-55877766EAE6Q34077471-BC9A4AA7-4A07-4E2F-9EBD-4FF83F3F6362Q34368364-D50D44C2-D17A-4300-879A-3AD0A413E4A3Q34598267-D3AF32BF-8D74-4CFF-87B2-15BD5D9AC93FQ34700034-A798D3B4-5A89-457F-9A45-23E289E24CD8Q34723072-16DB77B4-517E-4C6E-AC14-53980AA4D95AQ35010535-327BD1EC-17D7-4E7E-89C1-840D7C502905Q35010847-D48FDBD4-41B8-4E4A-9DB6-C02AFA17172BQ35020824-FD6F3CC6-CC96-49A0-A136-F47793F5D779Q35117727-B1D54D53-91DC-4745-B8C1-DE73CE5CD15BQ35224439-2B1A0DBB-A0A5-467D-AEA4-C5B75B3CD2CAQ35917541-0EC91EF6-BB75-46FF-8709-FD119948508AQ35925551-25F18ACE-F0BD-42B3-B7A2-448898B521ACQ35967369-7526A134-F0DD-4224-BE6C-EAF2CFD9DD04Q36048711-5A055067-AC98-4B93-99B4-AF650D57FA02Q36050544-D761AFA5-9AC2-47E1-8037-5876F480BA2FQ36135493-1C7673AD-7D19-44BA-92E5-F93F98E5F406Q36177722-58785BBB-2753-466F-A5AB-D6D5BB5A1A2AQ36178096-0DBEF921-4DC1-4DDE-82BF-D48A2C1F61D6Q36180349-251DAA38-649D-4888-82EC-4877C920430CQ36180475-225ECE56-BB13-47AC-B9FC-2F2CF6943E62Q36190413-F20F37C8-7FA7-4D6E-8DBA-DE2A10E6CBE0Q36234130-046383C5-C279-4A47-869F-BDD1279F6DDDQ36242833-1194ED08-5FFF-4A4C-9AEB-C520A83A18D6Q36338675-696AF04F-9683-41B4-B7E7-50C8D266D693Q36357716-A99DEF06-F463-4F7C-8474-F5D8A090619BQ36382634-2CEA4267-3E03-4667-B5E4-4477513E2828Q36453672-4DD74F60-5F03-4CAA-9AB6-56CBB4B14CBEQ36478120-3E29188E-F356-43ED-B7D7-A9C067865768Q36632233-68A0DA9A-2588-4797-A433-9781DC68AFA7Q36841560-21A8DAA5-5570-48CD-B2E2-D3DA96EC0849Q37128311-A8F00282-DC92-42FC-BCEA-797D58779441Q37195244-0649C30D-9CE2-494B-B059-B1ED69479455
P2860
Hepatitis B genotypes and the response to interferon therapy
description
article
@en
im Dezember 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2000
@uk
name
Hepatitis B genotypes and the response to interferon therapy
@en
Hepatitis B genotypes and the response to interferon therapy
@nl
type
label
Hepatitis B genotypes and the response to interferon therapy
@en
Hepatitis B genotypes and the response to interferon therapy
@nl
prefLabel
Hepatitis B genotypes and the response to interferon therapy
@en
Hepatitis B genotypes and the response to interferon therapy
@nl
P2093
P1476
Hepatitis B genotypes and the response to interferon therapy
@en
P2093
P304
P356
10.1016/S0168-8278(00)80135-X
P577
2000-12-01T00:00:00Z